Prince Pharmaceutical Co., Ltd. (TPEX: 6935)
Health Care · Pharmaceuticals · TW
NT$29.15
-7.46% today · +11.7% 1Y
Prince Pharmaceutical Co., Ltd. (TPEX: 6935) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $33.35M and employs 216 people.
Over the last twelve months the share price has gained 11.7%, trading between 24.90 and 35.85.
Tweenvest scores Prince Pharmaceutical Co., Ltd. across four factors: quality 62/100, value 70/100, dividend 19/100. Its strongest factor is value.
6935 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.35M
- Revenue (TTM)
- $33.63M
- P/E
- 11.17
- EPS
- 2.61
- Dividend yield
- 1.72%
- Beta (5Y)
- 0.61
- 52-week high
- NT$35.85
- 52-week low
- NT$24.90
- Avg volume (3M)
- —
- Shares outstanding
- 36.60M
- Employees
- 216
- Next earnings
- —
About Prince Pharmaceutical Co., Ltd.
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
- ISIN
- TW0006935000
- Founded
- 1962
- Listed since
- Mar 29, 2023
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.